359 related articles for article (PubMed ID: 29934224)
1. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial.
Pouw RE; Künzli HT; Bisschops R; Sondermeijer CM; Koch AD; Didden P; Gotink AW; Schoon EJ; Curvers WL; Bergman JJGHM; Weusten BLAM
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):566-574. PubMed ID: 29934224
[TBL] [Abstract][Full Text] [Related]
2. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
[TBL] [Abstract][Full Text] [Related]
3. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
[TBL] [Abstract][Full Text] [Related]
4. A simplified regimen for focal radiofrequency ablation of Barrett's mucosa: a randomized multicenter trial comparing two ablation regimens.
van Vilsteren FG; Phoa KN; Alvarez Herrero L; Pouw RE; Sondermeijer CM; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Weusten BL; Schoon EJ; Bergman JJ
Gastrointest Endosc; 2013 Jul; 78(1):30-8. PubMed ID: 23528655
[TBL] [Abstract][Full Text] [Related]
5. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation in Barrett's esophagus with dysplasia.
Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period.
van Munster S; Nieuwenhuis E; Weusten BLAM; Alvarez Herrero L; Bogte A; Alkhalaf A; Schenk BE; Schoon EJ; Curvers W; Koch AD; van de Ven SEM; de Jonge PJF; Tang TJ; Nagengast WB; Peters FTM; Westerhof J; Houben MHMG; Bergman JJ; Pouw RE;
Gut; 2022 Feb; 71(2):265-276. PubMed ID: 33753417
[TBL] [Abstract][Full Text] [Related]
9. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
10. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
[TBL] [Abstract][Full Text] [Related]
11. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Krishnadath KK; Ten Kate F; Fockens P; Bergman JJ
Endoscopy; 2008 May; 40(5):359-69. PubMed ID: 18494131
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
[TBL] [Abstract][Full Text] [Related]
13. Circumferential balloon-based radiofrequency ablation of Barrett's esophagus with dysplasia can be simplified, yet efficacy maintained, by omitting the cleaning phase.
van Vilsteren FG; Phoa KN; Alvarez Herrero L; Pouw RE; Sondermeijer CM; van Lijnschoten I; Seldenrijk KA; Visser M; Meijer SL; van Berge Henegouwen MI; Weusten BL; Schoon EJ; Bergman JJ
Clin Gastroenterol Hepatol; 2013 May; 11(5):491-98.e1. PubMed ID: 23267867
[TBL] [Abstract][Full Text] [Related]
14. Self-sizing radiofrequency ablation balloon for eradication of Barrett's esophagus: results of an international multicenter randomized trial comparing 3 different treatment regimens.
Belghazi K; Pouw RE; Koch AD; Weusten BLAM; Schoon EJ; Curvers WL; Gotink AW; Mostafavi N; Haidry RJ; Pech O; Bergman JJGHM; Bisschops R
Gastrointest Endosc; 2019 Sep; 90(3):415-423. PubMed ID: 31108093
[TBL] [Abstract][Full Text] [Related]
15. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
[TBL] [Abstract][Full Text] [Related]
16. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study.
Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S
BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927
[TBL] [Abstract][Full Text] [Related]
17. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
18. Treatment for Barrett's oesophagus.
Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.
dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
